#AKILA SUBRAMANIAM REGISTRATION#
I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as. The Columbia University Medical Center IRB served as the centralized IRB for this study.Īll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. The details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ĭentralized Institutional Review Board approval was obtained (IRB-AAAT1906), and informed consent was obtained from all participants. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Funding Statementįunding: This study was funded by the US Centers for Disease Control and Prevention through Contract # 75D30120C08150 with Abt Associates. Competing Interest StatementĪll authors have completed the ICMJE uniform disclosure form at and declare: no support from any organization for the submitted work author CGB has an unrestricted grant from SMFM/AMAG to study prematurity. Racial and ethnic disparities in plans to accept COVID-19 vaccine highlight the need to prioritize strategies to address perceived barriers among groups at high risk for COVID-19. She completed her bachelor degree in Management Science from the.
Conclusion Although most pregnant women worried about COVID-19 illness, <50% were willing to get vaccinated during pregnancy. Akila Subramaniam about pregnancy and coronavirus, the vaccines, and the impact the virus. Akila Subramaniam is an Assistant Professor in the Division of Maternal-Fetal Medicine.
0 kommentar(er)
